This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Toray Industries, Inc.. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Shinnosuke Hayashi: Innovator in Therapeutic Agents
Introduction
Shinnosuke Hayashi is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of autoimmune diseases and alopecia areata. With a total of 2 patents, his work is recognized for its innovative approach to medical treatments.
Latest Patents
Hayashi's latest patents include a therapeutic agent or preventive agent for alopecia areata. This agent exhibits RORγ antagonistic activity and includes a cyclic amine derivative as an active ingredient. His second patent focuses on a cyclic amine derivative that has retinoid-related orphan receptor γ antagonist activity. This compound shows therapeutic effects on autoimmune diseases such as multiple sclerosis and psoriasis, as well as allergic diseases like allergic dermatitis.
Career Highlights
Shinnosuke Hayashi is currently employed at Toray Industries, Inc., where he continues to develop innovative solutions in the medical field. His work has garnered attention for its potential impact on treating complex health issues.
Collaborations
Hayashi collaborates with esteemed colleagues, including Martial Vallet and Shinya Yokosaka, to advance research and development in his area of expertise.
Conclusion
Shinnosuke Hayashi's contributions to the field of therapeutic agents highlight his commitment to innovation and improving health outcomes. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
